We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $23.8B Turnover 13.57%
1-Year Est. Return 34.14%
 

Macquarie Group is an Australian financial services group that started in 1969 as Hill Samuel Australia, a subsidiary of the UK firm Hill Samuel. Businessman Stan Owens, who proposed the Australian arm to Hill Samuel, became its executive chairman and founded the company. It entered infrastructure investing in 1994 by underwriting shares for Sydney's Hills Motorway, and it specialises in sectors such as renewables, technology, resources and energy. In 2010 it bought Delaware Investments, an American asset manager, from Lincoln Financial Group, and in April 2025 it agreed to sell its US and European public asset management businesses.

This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
+34.14%
3 Year Est. Return
+127.83%
5 Year Est. Return
+149.46%
10 Year Est. Return
+479.84%
AUM
$50.9B
AUM Growth
+$1.3B
Cap. Flow
-$1.07B
Cap. Flow %
-2.1%
Top 10 Hldgs %
15.25%
Holding
1,701
New
146
Increased
583
Reduced
501
Closed
151
Avg Time Held
2.1 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$79.4M
2
CVS icon
CVS Health
CVS
+$68M
3
IWN icon
iShares Russell 2000 Value ETF
IWN
+$55.3M
4
UBS icon
UBS Group
UBS
+$54.6M
5
INTC icon
Intel
INTC
+$53M

Top Sells

Rank Stock Value
1
BXLT
Baxalta
BXLT
+$737M
2
QCOM icon
Qualcomm
QCOM
+$92.3M
3
BHC icon
Bausch Health
BHC
+$71M
4
HAL icon
Halliburton
HAL
+$53.1M
5
NVO icon
Novo Nordisk
NVO
+$53.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.25%
2 Financials 13.82%
3 Industrials 11.25%
4 Technology 10.93%
5 Energy 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
T icon
1
AT&T
T
$147B
$798M 1.57%
24,459,017
+104,070
+0.4% +$3.1M
2013 Q2
12 quarters
HAL icon
2
Halliburton
HAL
$26.2B
$792M 1.55%
17,477,865
-1,291,510
-7% -$53.1M
2013 Q2
12 quarters
EIX icon
3
Edison International
EIX
$24.2B
$791M 1.55%
10,185,545
-247,065
-2% -$17.7M
2013 Q2
12 quarters
PFE icon
4
Pfizer
PFE
$157B
$786M 1.54%
23,531,137
+58,904
+0.3% +$1.88M
2013 Q2
12 quarters
JNJ icon
5
Johnson & Johnson
JNJ
$643B
$786M 1.54%
6,480,273
-115,905
-2% -$13.2M
2013 Q2
12 quarters
VZ icon
6
Verizon
VZ
$190B
$783M 1.54%
14,029,001
+650,267
+5% +$33.7M
2013 Q2
12 quarters
DGX icon
7
Quest Diagnostics
DGX
$28.5B
$769M 1.51%
9,449,405
-447,236
-5% -$34.1M
2013 Q2
12 quarters
WM icon
8
Waste Management
WM
$94.9B
$764M 1.5%
11,521,184
-168,628
-1% -$10.2M
2013 Q2
12 quarters
ADM icon
9
Archer Daniels Midland
ADM
$31.9B
$753M 1.48%
17,552,154
-243,050
-1% -$9.7M
2013 Q2
12 quarters
INTC icon
10
Intel
INTC
$296B
$743M 1.46%
22,660,904
+1,690,347
+8% +$53M
2013 Q2
12 quarters
KHC icon
11
Kraft Heinz
KHC
$29.5B
$741M 1.46%
8,376,251
-204,661
-2% -$16.8M
2015 Q3
3 quarters
CVX icon
12
Chevron
CVX
$403B
$741M 1.45%
7,067,285
-250,587
-3% -$25.2M
2013 Q2
12 quarters
MDLZ icon
13
Mondelez International
MDLZ
$83.2B
$740M 1.45%
16,256,406
+128,759
+0.8% +$5.61M
2013 Q2
12 quarters
CVS icon
14
CVS Health
CVS
$102B
$738M 1.45%
7,707,523
+682,784
+10% +$68M
2013 Q2
12 quarters
NOC icon
15
Northrop Grumman
NOC
$77B
$737M 1.45%
3,316,885
-184,497
-5% -$38.8M
2013 Q2
12 quarters
LOW icon
16
Lowe's Companies
LOW
$123B
$737M 1.45%
9,311,165
-53,555
-0.6% -$4.14M
2013 Q2
12 quarters
MRK icon
17
Merck
MRK
$327B
$733M 1.44%
13,338,617
+148,218
+1% +$7.89M
2013 Q2
12 quarters
ALL icon
18
Allstate
ALL
$66B
$732M 1.44%
10,458,406
+296,985
+3% +$19.9M
2013 Q2
12 quarters
JCI icon
19
Johnson Controls International
JCI
$81.6B
$730M 1.43%
15,759,899
-217,225
-1% -$9.6M
2013 Q2
12 quarters
MRSH icon
20
Marsh
MRSH
$97.3B
$730M 1.43%
10,662,019
-696,551
-6% -$44.7M
2013 Q2
12 quarters
CSCO icon
21
Cisco
CSCO
$373B
$729M 1.43%
25,399,541
-38,531
-0.2% -$1.08M
2013 Q2
12 quarters
CA icon
22
DELISTED
CA Inc
CA
$726M 1.43%
22,107,439
+77,866
+0.4% +$2.44M
2013 Q2
12 quarters
ESRX
23
DELISTED
Express Scripts Holding
ESRX
$720M 1.41%
9,500,765
-49,554
-0.5% -$3.64M
2013 Q2
12 quarters
OXY icon
24
Occidental Petroleum
OXY
$53.8B
$718M 1.41%
9,505,449
+70,978
+0.8% +$5.3M
2013 Q2
12 quarters
TFC icon
25
Truist Financial
TFC
$55.9B
$713M 1.4%
20,026,105
+1,289,115
+7% +$45M
2013 Q2
12 quarters

Similar funds

Macquarie Group's Q2 2016 Portfolio in Review

As of Q2 2016, Macquarie Group held 1,701 positions worth $50.9B, up 2.6% from $49.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Macquarie Group's Q2 2016 filing shows 146 new, 583 increased, 501 reduced and 151 closed positions. Its largest new stake was iShares Russell 2000 Value ETF: 580,847 shares worth $56.5M. The largest sale was Baxalta, an estimated $737M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Financials and Industrials.

  • Macquarie Group's largest Q2 2016 buy was iShares Russell 2000 Value ETF: 580,847 shares worth $56.5M.
  • Macquarie Group added most to Cardinal Health in Q2 2016, an estimated $79.4M increase.
  • Macquarie Group's biggest Q2 2016 reduction was Baxalta, cutting an estimated $737M.
  • Macquarie Group fully exited Bausch Health in Q2 2016, selling an estimated $71M.
  • Macquarie Group's ten largest holdings make up 15% of its $50.9B portfolio in Q2 2016.
  • Macquarie Group opened 146 new positions and closed 151 in Q2 2016.
  • Macquarie Group's portfolio value rose 2.6% quarter-over-quarter to $50.9B.

Based on Macquarie Group's 13F filing for Q2 2016, filed 15 Aug 2016.